Description
Cabazitaxel, marketed under the brand name Kabanat, It is an prescription medication that has been approved cabazitaxel on June 17, 2010 for the treatment of hormone-refractory metastatic prostate cancer. It was the first cytotoxic agent to demonstrate a survival benefit in patients with castration-resistant prostate cancer (CRPC) who had previously been treated with docetaxel.
What is Kabanat (Cabazitaxel) ?
Kabanat Injection belongs to the general group of medicines called antineoplastics. It is used for the treatment of advanced prostate cancer. It works by interfering with the growth of cancer cells, which are eventually destroyed.
Cabazitaxel (previously XRP-6258, trade name Jevtana) is a semi-synthetic derivative of a natural taxoid. It was developed by Sanofi-Aventis and was approved by the U.S. FDA for the treatment of hormone-refractory prostate cancer on June 17, 2010. It is a microtubule inhibitor, and the fourth taxane to be approved as a cancer therapy. Cabazitaxel in combination with prednisone is a treatment option for hormone-refractory prostate cancer following docetaxel-based treatment.
How to order approved “Kabanat (Cabazitaxel) for Injection” Medicine?
Kabanat (Cabazitaxel) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing Kabanat and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
